Status:

NOT_YET_RECRUITING

The Effect of Wet Cupping Therapy on Headache and Migraine-related Disability

Lead Sponsor:

Mersin University

Conditions:

Migraine-related Headache

Eligibility:

All Genders

18-64 years

Phase:

NA

Brief Summary

Objective: This study aims to investigate the effects of wet cupping therapy (cupping) applied once to the head and neck region on the severity of headache and disability in patients diagnosed with mi...

Detailed Description

The cupping application, which has a very old history and varies in different countries and cultures, is preferred especially in Islamic geography as wet cupping application and in Far Eastern countri...

Eligibility Criteria

Inclusion

  • Those between the ages of 18-65,
  • Those who are literate, speak Turkish and have no communication problems,
  • Those diagnosed with migraine according to the International Classification of Headache Disorders (ICHD-3),
  • Those who have had headaches for the last three months and are receiving medical treatment for this reason,
  • Those who want to have cupping therapy,
  • Those who do not have any bleeding or coagulation disorders,
  • Those who have not had wet cupping therapy in the last three months,
  • Those who have a contraindication for wet cupping therapy (e.g. hemoglobin values below 9.5 gr/dl, INR below 1.5),
  • Those who do not have a history of malignancy,
  • Those who do not have an open wound in the application area,
  • Those who do not have any psychiatric disorders

Exclusion

  • Patients with any incurable disease,
  • Patients with a physical disability in the area where the application will be made,
  • Patients with any skin disease in the area where the application will be made,
  • Patients with large scar tissue in the area where the application will be made,
  • Patients with a history of physical trauma in the area where the application will be made in the last three months,
  • Patients with any peripheral vascular disease in the area where the application will be made,
  • Patients who have used any complementary and integrative health application in the last three months,
  • Patients who have received pain blockade treatment in the last year

Key Trial Info

Start Date :

September 23 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 17 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06568757

Start Date

September 23 2024

End Date

March 17 2025

Last Update

August 23 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.